Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Jurković, , Jele,
DOB: 07-JAN-1953 (Age: 72)
Gender: female
Address:
Klesarski put 7b/8
34310 Pleternica (Croatia)
ID: 3583-291434-1 (ECI)
Report
Date: 18-JAN-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Opća županijska bolnica Požega
Osječka ulica 107
34000 Požega (Croatia)
Specimen
Collected: 18-JAN-2017

Chemistry

Test 18-JAN-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4 - 6 %
Glucose [Mass/volume] in Blood 87.7 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.0 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.5 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.2 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 136.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 108.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.3 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 165.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 138.5 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 102.8 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.9 L 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c (6.4%), indicating impaired glucose control or possible diabetes. All other metabolic and renal parameters are within normal limits. Lipid profile reveals low HDL cholesterol (34.9 mg/dL), which is a cardiovascular risk factor. Recommend further evaluation and management of glycemic control and measures to increase HDL.